- Home
- NEOV vs DRRX Comparison
NEOV vs DRRX Comparison
Compare NEOV & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- DRRX
- Stock Information
- Founded
- NEOV 2018
- DRRX 1998
- Country
- NEOV United States
- DRRX United States
- Employees
- NEOV N/A
- DRRX N/A
- Industry
- NEOV Industrial Machinery/Components
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- NEOV Miscellaneous
- DRRX Health Care
- Exchange
- NEOV Nasdaq
- DRRX Nasdaq
- Market Cap
- NEOV 72.2M
- DRRX 59.0M
- IPO Year
- NEOV N/A
- DRRX 2000
- Fundamental
- Price
- NEOV $4.22
- DRRX $1.91
- Analyst Decision
- NEOV Strong Buy
- DRRX Hold
- Analyst Count
- NEOV 1
- DRRX 1
- Target Price
- NEOV $7.50
- DRRX N/A
- AVG Volume (30 Days)
- NEOV 302.5K
- DRRX 2.9M
- Earning Date
- NEOV 09-26-2025
- DRRX 08-12-2025
- Dividend Yield
- NEOV N/A
- DRRX N/A
- EPS Growth
- NEOV N/A
- DRRX N/A
- EPS
- NEOV N/A
- DRRX N/A
- Revenue
- NEOV $4,255,136.00
- DRRX $1,657,000.00
- Revenue This Year
- NEOV $208.50
- DRRX N/A
- Revenue Next Year
- NEOV $128.75
- DRRX $673.00
- P/E Ratio
- NEOV N/A
- DRRX N/A
- Revenue Growth
- NEOV 52.64
- DRRX N/A
- 52 Week Low
- NEOV $1.80
- DRRX $0.48
- 52 Week High
- NEOV $6.11
- DRRX $2.64
- Technical
- Relative Strength Index (RSI)
- NEOV 45.99
- DRRX 84.64
- Support Level
- NEOV $3.55
- DRRX $1.85
- Resistance Level
- NEOV $5.38
- DRRX $1.92
- Average True Range (ATR)
- NEOV 0.51
- DRRX 0.09
- MACD
- NEOV -0.17
- DRRX 0.01
- Stochastic Oscillator
- NEOV 36.61
- DRRX 10.98
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.